|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
NTLA | Lebwohl David | EVP, Chief Medical Officer | Jan 03 | Sale | 29.46 | 5,843 | 172,135 | 54,372 | Jan 05 04:50 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Jan 04 | Sale | 37.21 | 2,574 | 95,779 | 25,687 | Jan 06 05:26 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Jan 01 | Sale | 112.24 | 1,051 | 117,964 | 10,922 | Mar 03 08:00 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Nov 05 | Option Exercise | 12.62 | 2,400 | 30,288 | 11,114 | Nov 09 06:08 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Nov 05 | Sale | 132.72 | 2,400 | 318,535 | 8,714 | Nov 09 06:08 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Oct 14 | Option Exercise | 12.62 | 2,400 | 30,288 | 11,114 | Oct 15 07:02 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Oct 14 | Sale | 128.44 | 2,400 | 308,249 | 8,714 | Oct 15 07:02 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Sep 24 | Option Exercise | 12.62 | 7,923 | 99,988 | 8,714 | Sep 27 04:15 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Sep 21 | Option Exercise | 12.62 | 2,400 | 30,288 | 3,191 | Sep 23 05:48 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Sep 21 | Sale | 149.81 | 2,400 | 359,544 | 791 | Sep 23 05:48 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Aug 30 | Option Exercise | 12.62 | 2,400 | 30,288 | 3,191 | Sep 01 07:32 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Aug 30 | Sale | 158.04 | 2,400 | 379,300 | 791 | Sep 01 07:32 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Aug 09 | Option Exercise | 12.62 | 2,400 | 30,288 | 3,191 | Aug 11 04:50 PM |
NTLA | Lebwohl David | EVP, Chief Medical Officer | Aug 09 | Sale | 164.05 | 2,400 | 393,720 | 791 | Aug 11 04:50 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite